Name: Ann-Christin Pålsson Age: 49 years Function at IVL: Senior project manager at IVL’s Gothenburg office. Works in consultancy assignments and projects focusing on sustainability management and sustainable value chains, at both a strategic and an operational level. Background: M.Sc. in Engineering Physics and Ph.D. in Industrial Environmental Informatics. Joined IVL in August 2017 and has previously driven the development of environmental and sustainability work at various companies and at Chalmers.
AN ENVIRONMENTAL ASSESSMENT MODEL FOR PHARMACEUTICALS • The environmental assessment model will deliver reliable, comparable and relevant information about the environmental impact of pharmaceuticals from a life cycle perspective. This will make it possible to compare the environmental impact of products containing the same active substance. • The model covers environmental risks in the case of emissions of active pharmaceutical substances during production and use, as well as the carbon footprint from a life cycle perspective.
IVL CONTRIBUTES TO THE GLOBAL GOALS BY: • 3.9 Reducing instances of illness and death caused by harmful chemicals and pollutants • 6.3 Improving water quality and sewage treatment as well as increasing reuse • 8.4 Improving resource efficiency in consumption and production • 12.4 Responsible management of chemicals and waste • 12.6 Encouraging companies to apply sustainable methods and sustainability reporting • 12.7 Promoting sustainable public procurement methods, in line with national policies and priorities. • 12.8 Increasing public awareness of sustainable lifestyles • 13.2 Integrating measures to combat climate change into policies and planning • 14.1 Reducing marine pollution • 17.17 Encourage effective partnerships
• The information can be used by various actors and for various applications. For example, to reward alternatives that have less of an environmental impact in the exchange system for generic products and during public procurement within the regions, as well as in pharmacies to guide consumers in their choice of over-the-counter medicines. • The model has been developed by IVL Swedish Environmental Research Institute and Lif.
ANNUAL REPORT 2020
23
